Professor of Urology, Vanderbilt University
Urology
Dr. Daniel Barocas, MD
|
|
Give Review
Doctor Daniel Barocas, MD is an expert in the field of Urology. He studied medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He received awards:"Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Daniel Barocas is also published. He has 75 publications published. The lastest publication: "A case of chronic factitious disorder presenting as repeated, self-inflicted burns.' He accepts all Medicare patients.
Publications
- The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples.
- Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care.
- Increasing Use of Observation among Men at Low Risk for Prostate Cancer Mortality.
- The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update.
- Gender, Race, and Variation in the Evaluation of Microscopic Hematuria Among Medicare Beneficiaries.
- Influence of Age on Incident Diabetes and Cardiovascular Disease Among Prostate Cancer Survivors Receiving Androgen Deprivation Therapy.
- Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.
- Predictors of outcome in Bladder cancer.
- Knowledge of the harms of tobacco use among patients with Bladder cancer.
- Prostate Cancer early detection, version 1.2014.
- The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
- The Right Triangle.
- Locoregional small cell carcinoma of the Bladder: clinical characteristics and treatment patterns.
- Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate Cancer treatment.
- Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides.
- Roadmap for the development of the University of North Carolina at Chapel Hill GenitoUrinary OncoLogy Database-UNC GOLD.
- Racial variation in the quality of surgical care for Bladder cancer.
- Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive Bladder cancer.
- The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for Bladder cancer.
- Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.
- Delivering high-quality care to prostate Cancer survivors.
- Incidence and Predictors of Understaging in Patients with Clinical T1 Urothelial Carcinoma Undergoing Radical Cystectomy.
- Association between race and follow-up diagnostic care after a positive prostate Cancer screening test in the Prostate, Lung, Colorectal, and Ovarian Cancer screening ...
- Anatomic basis for lymph node counts as measure of lymph node dissection extent: a cadaveric study.
- Ureteroenteric anastomotic Strictures after radical cystectomy-does operative approach matter?
- Centralization of radical Prostatectomy in the United States.
- Salvage robotic assisted laparoscopic radical Prostatectomy: a single institution, 5-year experience.
- Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate Cancer--evidence of effect modification by prostate s...
- Volume outcomes of cystectomy--is it the surgeon or the setting?
- Economic and humanistic consequences of preventable Bladder tumor recurrences in nonmuscle invasive Bladder cancer cases.
- Diagnosis, evaluation and follow-up of asymptomatic microHematuria (AMH) in adults: AUA guideline.
- National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats.
- Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate Cancer.
- Predicting the probability of 90-day survival of elderly patients with Bladder cancer treated with radical cystectomy.
- Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical Prostatectomy specimens: a tale of two methods.
- Effect of preoperative nutritional deficiency on mortality after radical cystectomy for Bladder cancer.
- Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort.
- Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series.
- Comparative analysis of whole mount processing and systematic sampling of radical Prostatectomy specimens: pathological outcomes and risk of biochemical recurrence.
- Penile Cancer: clinical presentation, diagnosis, and staging.
- Smaller prostate size predicts high grade prostate Cancer at final pathology.
- Racial variation in the pattern and quality of care for prostate Cancer in the USA: mind the gap.
- Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for Bladder cancer.
- Radical nephrectomy surgical outcomes in the University HealthSystem Consortium Data Base: Impact of hospital case volume, hospital size, and geographic location on 40...
- Differential expression of KAI1 metastasis suppressor protein in Renal cell tumor histological subtypes.
- Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
- Oxidative stress measured by urine F2-isoprostane level is associated with prostate Cancer.
- Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate Cancer: comparison of short-term biochemical recu...
- Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical Prostatectomy.
- Pathological stage T2 subgroups to predict biochemical recurrence after Prostatectomy.
- Immediate surgical outcomes for radical Prostatectomy in the University HealthSystem Consortium Clinical Data Base: the impact of hospital case volume, hospital size a...
- Impact of surgeon and hospital volume on outcomes of radical Prostatectomy.
- What percentage of patients with newly diagnosed carcinoma of the Prostate are candidates for surveillance? An analysis of the CaPSURE database.
- Effect of a large Prostate gland on open and robotically assisted laparoscopic radical Prostatectomy.
- Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy.
- Risk assessment of prostatic pathology in patients undergoing radical cystoProstatectomy.
- Re: A multi-institution, minimally invasive urological oncology fellowship: a critical assessment of the clinical training and academic benefits. J. A. Brown and R. W....
- Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.
- Diagnosis of Renal tumors on needle biopsy specimens by histological and molecular analysis.
- A population-based study of renal cell carcinoma and prostate Cancer in the same patients.
- Five-alpha-reductase expression in benign and malignant urothelium: correlation with Disease characteristics and outcome.
- Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.
- Acute stress disorder after burn injury: a predictor of posttraumatic stress disorder?
- Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate Cancer?
- Acute intrusive and avoidant PTSD symptoms as predictors of Chronic PTSD following burn injury.
- A case of Chronic factitious disorder presenting as repeated, self-inflicted burns.
- Blood magnesium, and the interaction with calcium, on the risk of high-grade prostate Cancer.
- Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for Renal cell carcinoma.
- Successful control of schistosomiasis and the changing epidemiology of Bladder cancer in Egypt.
- The associations between statin use and prostate Cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate Cancer.
- Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined Bladder cancer.
- Comparison of transfusion requirements between open and robotic-assisted laparoscopic radical Prostatectomy.
- Outcomes of patients undergoing radical cystoprostatectomy for Bladder cancer with prostatic involvement on final pathology.
- Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for Bladder cancer.
Schools
Johns Hopkins University School of Medicine
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Vanderbilt University -
New York Presbyterian Hospital -
New York Presbyterian Hospital - Cornell Campus -
Johns Hopkins University School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1225259831 | |
| NPPES Provider LastName | BAROCAS | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 372325100 | |
| NPPES Provider State | TN | |
| Specialty Description | Urology | |
| Total Claim Count | 129.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225259831 |
| Last Name Of The Provider | BAROCAS |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
Dr. Sriram Dasari, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Phillip P. Porch III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer Tatalovich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harriette Scarpero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert H. Edwards, MD |
|
|
Dr. Benjamin L. Dehner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Hughes, MD |
|
|
Dr. Trisha M. Juliano, MD |
|
|
Dr. Deborah L. Jacobson, MD |
|
|
Dr. Christopher R. Mitchell, MD |